News

1 minute de lecture

IPSA Congress 2024

à lire également
Corporative
Bioprojet announces the signing of a strategic agreement with CR Sanjiu for the commercialization of WAKIX® in China
Bioprojet announces the signing of a strategic agreement with CR Sanjiu for the commercialization of WAKIX® in China
Health
Central disorders of hypersomnolence : first human clinical trial on BP1.15205
Central disorders of hypersomnolence : first human clinical trial on BP1.15205
Awards
November 2025 Events
November 2025 Events
Corporative
INSIDE BIOPROJET : Episode 3
INSIDE BIOPROJET : Episode 3
Voir toutes les actualités

Bioprojet will be present from April 26 to 28, 2024 at the 8th edition of the IPSA congress (International Pediatric Sleep Association), in Glasgow, Scotland.

Our symposium, on Sunday 28th at 12:15 PM, will be under the theme “Narcolepsy management in children through different European countries”.

  • Pr. Yves Dauvilliers: Drugs, studies, EUNN guidelines 2023
  • Pr. Giuseppe Plazzi : Patient pathway and management in Italy, a clinical case
  • Pr. Patricia Franco: Patient pathway and management in France, a clinical case